Published in J Cell Mol Med on March 27, 2009
TRAIL and vitamins: opting for keys to castle of cancer proteome instead of open sesame. Cancer Cell Int (2012) 0.81
AKT/PKB signaling: navigating downstream. Cell (2007) 31.26
Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer (2007) 6.18
Current understanding of the molecular actions of vitamin D. Physiol Rev (1998) 4.05
PKB/Akt: connecting phosphoinositide 3-kinase to cell survival and beyond. Trends Biochem Sci (1997) 3.68
Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev (1996) 3.49
Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J Cell Biol (2001) 3.44
New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab (2002) 2.77
Stress and adult neurogenesis. Hippocampus (2006) 2.74
PEA-15 mediates cytoplasmic sequestration of ERK MAP kinase. Dev Cell (2001) 2.73
Molecular cloning of complementary DNA encoding the avian receptor for vitamin D. Science (1987) 2.71
Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults. Am J Geriatr Psychiatry (2006) 2.08
Vitamin D3 and brain development. Neuroscience (2003) 2.01
Postnatal development of radial glia and the ventricular zone (VZ): a continuum of the neural stem cell compartment. Cereb Cortex (2003) 1.96
Multipotent neural stem cells reside into the rostral extension and olfactory bulb of adult rodents. J Neurosci (2002) 1.81
Induction and intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated apotosis in human malignant glioma cells. Cancer Res (2001) 1.70
Protein kinase B/Akt binds and phosphorylates PED/PEA-15, stabilizing its antiapoptotic action. Mol Cell Biol (2003) 1.67
AKT signaling within the ventral tegmental area regulates cellular and behavioral responses to stressful stimuli. Biol Psychiatry (2008) 1.60
Tumor necrosis factor-related apoptosis-inducing ligand-induced death-inducing signaling complex and its modulation by c-FLIP and PED/PEA-15 in glioma cells. J Biol Chem (2002) 1.54
Addressing the health benefits and risks, involving vitamin D or skin cancer, of increased sun exposure. Proc Natl Acad Sci U S A (2008) 1.53
Knock-out of the neural death effector domain protein PEA-15 demonstrates that its expression protects astrocytes from TNFalpha-induced apoptosis. J Neurosci (1999) 1.52
Vitamin D regulated keratinocyte differentiation. J Cell Biochem (2004) 1.51
PED/PEA-15: an anti-apoptotic molecule that regulates FAS/TNFR1-induced apoptosis. Oncogene (1999) 1.49
Establishment and properties of a growth factor-dependent, perpetual neural stem cell line from the human CNS. Exp Neurol (2000) 1.46
Evolution and function of vitamin D. Recent Results Cancer Res (2003) 1.43
Chronic stress: implications for neuronal morphology, function and neurogenesis. Front Neuroendocrinol (2007) 1.41
Pathological apoptosis in the developing brain. Apoptosis (2007) 1.38
The p38 and JNK pathways cooperate to trans-activate vitamin D receptor via c-Jun/AP-1 and sensitize human breast cancer cells to vitamin D(3)-induced growth inhibition. J Biol Chem (2002) 1.29
Inhibition of p38 by vitamin D reduces interleukin-6 production in normal prostate cells via mitogen-activated protein kinase phosphatase 5: implications for prostate cancer prevention by vitamin D. Cancer Res (2006) 1.28
1,25-Dihydroxycholecalciferol (1,25-D3) inhibits the growth of squamous cell carcinoma and down-modulates p21(Waf1/Cip1) in vitro and in vivo. Cancer Res (1999) 1.27
Calcium and calpain as key mediators of apoptosis-like death induced by vitamin D compounds in breast cancer cells. J Biol Chem (2002) 1.27
Death effector domain protein PEA-15 potentiates Ras activation of extracellular signal receptor-activated kinase by an adhesion-independent mechanism. Mol Biol Cell (2000) 1.22
Transient prenatal vitamin D deficiency is associated with subtle alterations in learning and memory functions in adult rats. Behav Brain Res (2005) 1.18
Apoptosis and brain development. Ment Retard Dev Disabil Res Rev (2001) 1.16
VDR gene variants associate with cognitive function and depressive symptoms in old age. Neurobiol Aging (2007) 1.16
Developmental Vitamin D3 deficiency alters the adult rat brain. Brain Res Bull (2005) 1.15
Cellular expression, developmental regulation, and phylogenic conservation of PEA-15, the astrocytic major phosphoprotein and protein kinase C substrate. J Neurochem (1995) 1.13
Developmental vitamin D deficiency alters brain protein expression in the adult rat: implications for neuropsychiatric disorders. Proteomics (2007) 1.13
Low maternal vitamin D as a risk factor for schizophrenia: a pilot study using banked sera. Schizophr Res (2003) 1.13
PED mediates AKT-dependent chemoresistance in human breast cancer cells. Cancer Res (2005) 1.12
Current understanding of the function of the nuclear vitamin D receptor in response to its natural and synthetic ligands. Recent Results Cancer Res (2003) 1.12
Human astrocytes are resistant to Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. J Neurosci (2006) 1.11
Osteoblast differentiation and control by vitamin D and vitamin D metabolites. Curr Pharm Des (2004) 1.11
Brain target sites for 1,25-dihydroxyvitamin D3. Science (1982) 1.11
Cross-talk of vitamin D and glucocorticoids in hippocampal cells. J Neurochem (2005) 1.08
The expression of PEA-15 (phosphoprotein enriched in astrocytes of 15 kDa) defines subpopulations of astrocytes and neurons throughout the adult mouse brain. Neuroscience (2004) 1.08
Selective inhibition of PED protein expression sensitizes B-cell chronic lymphocytic leukaemia cells to TRAIL-induced apoptosis. Int J Cancer (2007) 1.05
Vitamin D increases expression of the tyrosine hydroxylase gene in adrenal medullary cells. Brain Res Mol Brain Res (1996) 1.01
PED is overexpressed and mediates TRAIL resistance in human non-small cell lung cancer. J Cell Mol Med (2008) 0.99
Myths and plain truths about schizophrenia epidemiology--the NAPE lecture 2004. Acta Psychiatr Scand (2005) 0.98
Light, vitamin D and psychiatry. Role of 1,25 dihydroxyvitamin D3 (soltriol) in etiology and therapy of seasonal affective disorder and other mental processes. Psychopharmacology (Berl) (1989) 0.94
Autocrine TGFbeta signaling mediates vitamin D3 analog-induced growth inhibition in breast cells. J Cell Physiol (2001) 0.91
Genetically perpetuated human neural stem cells engraft and differentiate into the adult mammalian brain. Mol Cell Neurosci (2000) 0.90
Update on biological actions of 1alpha,25(OH)2-vitamin D3 (rapid effects) and 24R,25(OH)2-vitamin D3. Mol Cell Endocrinol (2002) 0.89
Growth and EGFR regulation in breast cancer cells by vitamin D and retinoid compounds. Breast Cancer Res Treat (2004) 0.89
Inhibition of F-Box protein p45(SKP2) expression and stabilization of cyclin-dependent kinase inhibitor p27(KIP1) in vitamin D analog-treated cancer cells. Endocrinology (2003) 0.88
Associations between cod liver oil use and symptoms of depression: the Hordaland Health Study. J Affect Disord (2006) 0.87
Treatment with dexamethasone and vitamin D3 attenuates neuroinflammatory age-related changes in rat hippocampus. Synapse (2007) 0.86
1,25-Dihydroxyvitamin D3 increases the growth-promoting activity of autocrine epidermal growth factor receptor ligands in keratinocytes. Endocrinology (1999) 0.86
Identification and characterization of a response element in the EGFR promoter that mediates transcriptional repression by 1,25-dihydroxyvitamin D3 in breast cancer cells. J Mol Endocrinol (2005) 0.86
Functional role of VDR in the activation of p27Kip1 by the VDR/Sp1 complex. J Cell Biochem (2006) 0.83
Differentiation-inducing liposoluble vitamin deficiency may explain frequent secondary solid tumors after hematopoietic stem cell transplantation: minireview. Neoplasma (2008) 0.77
Mass spectrometrical analysis of phosphoprotein enriched in astrocytes of 15 kDa in mouse hippocampi. Amino Acids (2004) 0.76
Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions. Nat Neurosci (2012) 4.71
miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation. Cancer Cell (2009) 4.48
Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat Genet (2004) 3.91
FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells. J Biol Chem (2004) 2.91
Cathepsin L and cathepsin B mediate reovirus disassembly in murine fibroblast cells. J Biol Chem (2002) 2.76
EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers. Nat Med (2011) 2.46
Impact of a high loading dose of atorvastatin on contrast-induced acute kidney injury. Circulation (2012) 2.44
Tumor cell-derived and macrophage-derived cathepsin B promotes progression and lung metastasis of mammary cancer. Cancer Res (2006) 2.20
Renal Insufficiency After Contrast Media Administration Trial II (REMEDIAL II): RenalGuard System in high-risk patients for contrast-induced acute kidney injury. Circulation (2011) 2.18
Relation of various plasma growth factor levels in patients with stable angina pectoris and total occlusion of a coronary artery to the degree of coronary collaterals. Am J Cardiol (2005) 2.14
The E3 ligase parkin maintains mitochondrial integrity by increasing linear ubiquitination of NEMO. Mol Cell (2013) 2.12
Akt mediates the cross-talk between beta-adrenergic and insulin receptors in neonatal cardiomyocytes. Circ Res (2004) 2.08
Novel approaches for preventing or limiting events in diabetic patients (Naples-diabetes) trial: a randomized comparison of 3 drug-eluting stents in diabetic patients. Circ Cardiovasc Interv (2011) 1.86
Gene expression patterns associated with posttraumatic stress disorder following exposure to the World Trade Center attacks. Biol Psychiatry (2009) 1.85
Protein kinase B/Akt binds and phosphorylates PED/PEA-15, stabilizing its antiapoptotic action. Mol Cell Biol (2003) 1.67
Synergistic antitumor effects of combined cathepsin B and cathepsin Z deficiencies on breast cancer progression and metastasis in mice. Proc Natl Acad Sci U S A (2010) 1.60
MiR-494 is regulated by ERK1/2 and modulates TRAIL-induced apoptosis in non-small-cell lung cancer through BIM down-regulation. Proc Natl Acad Sci U S A (2012) 1.52
Contrast agents and renal cell apoptosis. Eur Heart J (2008) 1.49
Comparison of coronary drug-eluting stents versus coronary artery bypass grafting in patients with diabetes mellitus. Am J Cardiol (2007) 1.48
Absence of caspase 8 and high expression of PED protect primitive neural cells from cell death. J Exp Med (2004) 1.38
Mitochondrial dysfunction and decrease in body weight of a transgenic knock-in mouse model for TDP-43. J Biol Chem (2014) 1.37
FK506 binding protein 5 shapes stress responsiveness: modulation of neuroendocrine reactivity and coping behavior. Biol Psychiatry (2011) 1.37
miR-212 increases tumor necrosis factor-related apoptosis-inducing ligand sensitivity in non-small cell lung cancer by targeting the antiapoptotic protein PED. Cancer Res (2010) 1.36
FKBP51 and FKBP52 in signaling and disease. Trends Endocrinol Metab (2011) 1.34
Thyroid functions of mouse cathepsins B, K, and L. J Clin Invest (2003) 1.33
Cofactor Tpr2 combines two TPR domains and a J domain to regulate the Hsp70/Hsp90 chaperone system. EMBO J (2003) 1.25
MicroRNAs in diseases and drug response. Curr Opin Pharmacol (2008) 1.23
Essential role of the unusual DNA-binding motif of BAG-1 for inhibition of the glucocorticoid receptor. J Biol Chem (2002) 1.19
Pitchfork regulates primary cilia disassembly and left-right asymmetry. Dev Cell (2010) 1.18
MiR-221/222 target the DNA methyltransferase MGMT in glioma cells. PLoS One (2013) 1.16
The involvement of FK506-binding protein 51 (FKBP5) in the behavioral and neuroendocrine effects of chronic social defeat stress. Neuropharmacology (2011) 1.15
Essential role of cofilin-1 in regulating thrombin-induced RelA/p65 nuclear translocation and intercellular adhesion molecule 1 (ICAM-1) expression in endothelial cells. J Biol Chem (2009) 1.13
Autocrine production of interleukin-4 and interleukin-10 is required for survival and growth of thyroid cancer cells. Cancer Res (2006) 1.13
Valproate and amitriptyline exert common and divergent influences on global and gene promoter-specific chromatin modifications in rat primary astrocytes. Neuropsychopharmacology (2009) 1.12
PED mediates AKT-dependent chemoresistance in human breast cancer cells. Cancer Res (2005) 1.12
Genetic markers for PTSD risk and resilience among survivors of the World Trade Center attacks. Dis Markers (2011) 1.11
Nkx6-1 controls the identity and fate of red nucleus and oculomotor neurons in the mouse midbrain. Development (2009) 1.11
Correlations between progression of coronary artery disease and circulating endothelial progenitor cells. FASEB J (2010) 1.10
The activated glucocorticoid receptor inhibits the transcription factor T-bet by direct protein-protein interaction. FASEB J (2007) 1.09
Cross-talk of vitamin D and glucocorticoids in hippocampal cells. J Neurochem (2005) 1.08
A neutralizing RNA aptamer against EGFR causes selective apoptotic cell death. PLoS One (2011) 1.08
Individual stress vulnerability is predicted by short-term memory and AMPA receptor subunit ratio in the hippocampus. J Neurosci (2010) 1.07
An integrated genome research network for studying the genetics of alcohol addiction. Addict Biol (2010) 1.07
Selective inhibition of PED protein expression sensitizes B-cell chronic lymphocytic leukaemia cells to TRAIL-induced apoptosis. Int J Cancer (2007) 1.05
Activity of the GR in G2 and mitosis. Mol Endocrinol (2002) 1.05
Spatial analysis of expression patterns predicts genetic interactions at the mid-hindbrain boundary. PLoS Comput Biol (2009) 1.03
DNA methylation may restrict but does not determine differential gene expression at the Sgy/Tead2 locus during mouse development. Mol Cell Biol (2004) 1.03
Zebrafish reward mutants reveal novel transcripts mediating the behavioral effects of amphetamine. Genome Biol (2009) 1.03
Epigenetic regulation of miR-212 expression in lung cancer. PLoS One (2011) 1.01
Differential impact of tetratricopeptide repeat proteins on the steroid hormone receptors. PLoS One (2010) 1.01
PML mediates glioblastoma resistance to mammalian target of rapamycin (mTOR)-targeted therapies. Proc Natl Acad Sci U S A (2013) 1.00
Nephrotoxicity of contrast media and protective effects of acetylcysteine. Arch Toxicol (2010) 1.00
The heat shock protein 90-targeting drug cisplatin selectively inhibits steroid receptor activation. Mol Endocrinol (2003) 1.00
PED is overexpressed and mediates TRAIL resistance in human non-small cell lung cancer. J Cell Mol Med (2008) 0.99
Suppression of microRNA-9 by mutant EGFR signaling upregulates FOXP1 to enhance glioblastoma tumorigenicity. Cancer Res (2014) 0.98
Inhibition of GR-mediated transcription by p23 requires interaction with Hsp90. FEBS Lett (2004) 0.97
Computational identification and experimental validation of microRNAs binding to the Alzheimer-related gene ADAM10. BMC Med Genet (2012) 0.96
DNA methylation dependent silencing of the human glutamate transporter EAAT2 gene in glial cells. Glia (2007) 0.95
TGF-beta signalling in the adult neurogenic niche promotes stem cell quiescence as well as generation of new neurons. J Cell Mol Med (2014) 0.95
A tale of two approaches: complementary mechanisms of cytotoxic and targeted therapy resistance may inform next-generation cancer treatments. Carcinogenesis (2013) 0.94
Cofilin 1 is revealed as an inhibitor of glucocorticoid receptor by analysis of hormone-resistant cells. Mol Cell Biol (2004) 0.94
Tumor suppressor down-regulated in renal cell carcinoma 1 (DRR1) is a stress-induced actin bundling factor that modulates synaptic efficacy and cognition. Proc Natl Acad Sci U S A (2011) 0.92
Distinct protease requirements for antigen presentation in vitro and in vivo. J Immunol (2010) 0.92
The mTOR kinase inhibitors, CC214-1 and CC214-2, preferentially block the growth of EGFRvIII-activated glioblastomas. Clin Cancer Res (2013) 0.91
Antidepressant drugs diversely affect autophagy pathways in astrocytes and neurons--dissociation from cholesterol homeostasis. Neuropsychopharmacology (2011) 0.91
Akt regulates drug-induced cell death through Bcl-w downregulation. PLoS One (2008) 0.91
Homer1 mediates acute stress-induced cognitive deficits in the dorsal hippocampus. J Neurosci (2013) 0.91
Assessment of the 9p21.3 locus in severity of coronary artery disease in the presence and absence of type 2 diabetes. BMC Med Genet (2013) 0.90
XAP2 inhibits glucocorticoid receptor activity in mammalian cells. FEBS Lett (2009) 0.89
Differential gene expression in ADAM10 and mutant ADAM10 transgenic mice. BMC Genomics (2009) 0.88
TNF-alpha signal transduction in rat neonatal cardiac myocytes: definition of pathways generating from the TNF-alpha receptor. FASEB J (2002) 0.88
Gene expression profiling following maternal deprivation: involvement of the brain Renin-Angiotensin system. Front Mol Neurosci (2009) 0.87
Sharpening of expression domains induced by transcription and microRNA regulation within a spatio-temporal model of mid-hindbrain boundary formation. BMC Syst Biol (2013) 0.87
Corticotropin-releasing factor (CRF) receptor type 1-dependent modulation of synaptic plasticity. Neurosci Lett (2007) 0.87
RSUME enhances glucocorticoid receptor SUMOylation and transcriptional activity. Mol Cell Biol (2013) 0.86
Conditional RNAi in mice. Methods (2010) 0.85
The CpG island shore of the GLT-1 gene acts as a methylation-sensitive enhancer. Glia (2012) 0.84
Recent Advance in Biosensors for microRNAs Detection in Cancer. Cancers (Basel) (2011) 0.84
N-desalkylquetiapine activates ERK1/2 to induce GDNF release in C6 glioma cells: a putative cellular mechanism for quetiapine as antidepressant. Neuropharmacology (2011) 0.83
Elevated expression of the tyrosine phosphatase SHP-1 defines a subset of high-grade breast tumors. Oncology (2010) 0.83
Epigenetic aspects of posttraumatic stress disorder. Dis Markers (2011) 0.83
Phosphorylation-regulated degradation of the tumor-suppressor form of PED by chaperone-mediated autophagy in lung cancer cells. J Cell Physiol (2014) 0.83
Gene expression profiling in the stress control brain region hypothalamic paraventricular nucleus reveals a novel gene network including amyloid beta precursor protein. BMC Genomics (2010) 0.83
Antidepressants inhibit DNA methyltransferase 1 through reducing G9a levels. Biochem J (2012) 0.83
PED interacts with Rac1 and regulates cell migration/invasion processes in human non-small cell lung cancer cells. J Cell Physiol (2010) 0.83
Impact of lipid raft integrity on 5-HT3 receptor function and its modulation by antidepressants. Neuropsychopharmacology (2010) 0.82
Antidepressants differentially influence the transcriptional activity of the glucocorticoid receptor in vitro. Neuroendocrinology (2003) 0.82
BAG-1 diversely affects steroid receptor activity. Biochem J (2012) 0.82
Bioinformatics identification of modules of transcription factor binding sites in Alzheimer's disease-related genes by in silico promoter analysis and microarrays. Int J Alzheimers Dis (2011) 0.81
Shp2 in PC12 cells: NGF versus EGF signalling. Cell Signal (2007) 0.81
"ApoptomiRs" in vascular cells: their role in physiological and pathological angiogenesis. Vascul Pharmacol (2011) 0.80